MD

Manoj Devi

Active Director Director DIN 09565615
DIN 09565615 First appointment Apr 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value •••• Premium profile

About Manoj Devi

Data last updated:

Manoj Devi is a Director at Alik Pharmaceutical Private Limited (since 2022). The company operates in Pharma. Alik Pharmaceutical Private Limited reported revenue of ₹1.42 Cr (FY 2026).

DIN 09565615
Primary Designation Director
Industry Pharma
First Appointment 08 Apr 2022
Oldest Company Age 12 yrs
Largest company Alik Pharmaceutical Private Limited · ₹1.42 Cr (FY 2026)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alik Pharmaceutical Private Limited U51397DL2014PTC266845
Director08 Apr 20222014₹1.42 Cr (FY 2026)Active

Board colleagues of Manoj Devi

Directorship timeline

Open interactive timeline →
Alik Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Manoj Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manoj Devi

Manoj Devi currently holds 1 directorship: Alik Pharmaceutical Private Limited (Director, since 08 Apr 2022, revenue ₹1.42 Cr (FY 2026)).

Manoj Devi was first appointed on 08 Apr 2022 as Director at Alik Pharmaceutical Private Limited.

The current boards of Manoj Devi's companies include Mukesh Tomar (Alik Pharmaceutical Private Limited), Vineet Srivastava (Alik Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available